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Abstract
Background: Infective endocarditis (IE) is a rare and feared 
infection that mainly occurs in patients with underlying 
cardiac disease or altered function of the immune system. 
Recent epidemiological data on both sepsis and nosocomial 
infections indicate a rise in gram-negative bacterial and 
fungal infection, particularly in patients requiring critical 
care support. This study sought to characterize the change 
in the spectrum of IE encountered in a single pediatric 
tertiary care center during the last 18 years, to evaluate 
emergence of fungal IE and to identify contributing factors.
Patients and Methods: Review of all cases of IE diagnosed 
between January 1986 and August 2003 at a single 
university children’s hospital. Patients were distributed 
between two equal time periods and compared according to 
the era of IE diagnosis.
Results: In 43 patients, 44 episodes of IE were identified 
with most cases occurring in children with congenital or 
acquired heart disease. The annual number of diagnosed 
cases fluctuated during the study (mean 2.4 cases/year). 
Blood or specimen cultures were positive in 34 cases (77%) 
with gram-positive organisms most frequently observed 
(n = 20, 44.4%). Fungal IE cases (n = 9, 20%) occurred 
preferentially during the second period (p < 0.03), and were 
more common in children with noncardiac diseases 
(p = 0.023). Factors associated with fungal IE were the use 
of broad-spectrum antibiotics (p < 0.001) and the presence 
of an infected central venous catheter (p = 0.01). Overall 
mortality did not differ between the two eras. 
Conclusion: The incidence of fungal IE seems to have 
significantly increased in more recent years. Use of broad-
spectrum antibiotics for prolonged time or/and central 
venous catheters were identified as predisposing factors to 
fungal infective endocarditis. 
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Introduction
Infective endocarditis (IE) is a feared complication of 
structural heart disease and, although rare in children, is 
associated with a significant morbidity and mortality [1]. 
Previous studies in children indicated that gram-positive 
cocci were responsible in up to 80% of IE cases, whereas 
fungi accounted for only 1 to 13% of infections (Table 1) 
[2–11]. The reported overall mortality rate ranges between 
5% and 25%. Nevertheless, the spectrum of organisms may 
have substantially changed in recent years because of the 
widespread use of intravascular catheters, critical care 
support, improved survival of congenital heart disease pa-
tients, better diagnostic methods (microbiology, echocar-
diography) as well as the use and abuse of antimicrobial 
drugs. Recent epidemiological studies outlined an increase 
in fungemia during recent decades [12–14]. We aimed to 
analyze possible recent changes in the pattern of pediatric 
IE and to identify risk factors.   
Patients and Methods 
Patients
Retrospective case review of all episodes of IE that occurred 
between January 1986 and August 2003 in a tertiary university 
children’s hospital. The diagnosis of IE was based on the modi-
fied Duke criteria using echocardiographic, microbiological, and 
pathological findings [15]. In order to evaluate the secular trend 
of the IE bacteriological pattern over the studied period, patients 
were divided into two equal time periods, ranging from 1986 to 
1994 (group 1) and from 1995 to 2003 (group 2). 
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Definition
A catheter-borne IE was considered if a vegetation was identi-
fied echocardiographically on the tip of a central venous catheter 
and if more than 103 colony-forming units per centimeter of an 
isolated microorganism were quantified in the culture of the cath-
eter tip [16]. 
Microbiology
Daily, one to two blood samples were systematically drawn in 
all cases with suspected IE and usually cultured for 21 days un-
der aerobic and anaerobic conditions. All microorganisms were 
identified using standardized procedures at the hospital’s central 
laboratory of bacteriology. The samples were distributed into 
a Septi-Chek Release bottle (Becton Dickinson, Cockeysville, 
MD) and an Oxoid Signal bottle (Oxoid, Basingstoke, UK). 
Whenever fungemia was suspected, the inoculation of an Isola-
tor 10/1.5 tube (Wampole Laboratories, Cranbury, NJ) based 
on lysis centrifugation was performed. With the introduction of 
an automated fluorometric BACTEC 9000 system in the clinical 
microbiology bacteriology laboratory (August 1994), the Septi-
Chek Release and Signal vials were replaced by the BACTEC 
Plus aerobic/F, BACTEC PEDS Plus /F and the Lytic anaero-
bic/F vials (Becton Dickinson, Sparks, MD). The Isolator was 
replaced when the BACTEC Myco/F Lytic medium became 
available (November 1997). Yeasts growing in all cultures were 
identified with API C32 (BioMérieux, Lyon, France) in conjunc-
tion with microscopic morphology of the fungi subcultured on 
rice agar. In one case of Bartonella quintana IE, broad-range 
PCR amplification was performed on excised mitral valvular tis-
sue, sequenced and compared with sequences of bacterial 16S 
ribosomal RNA genes deposited in Genebank and the European 
Molecular Biology Laboratory database [17, 18].
Echocardiography
All children underwent complete transthoracic 2-dimensional 
and Doppler echocardiographic studies at diagnosis and follow-
up using Vingmed Diasonics, CFM 700 or System Five ultrasound 
systems with 5 to 7 MHz phased-array transducers. Because of 
inconclusive transthoracic echocardiographic exam, nine patients 
underwent additional transesophageal echocardiography with a 5 
MHz multiplane probe. Unlike in adults, transthoracic and trans-
esophageal echocardiographies are considered equally accurate 
for the diagnosis of IE in children, in particular for the detection 
of vegetations [19]. All ultrasound studies were videotaped and 
available for off-line analyses. 
Statistics
To determine differences between groups, nonparametric Mann-
Whitney U test and a two-tailed Fisher's exact test were per-
formed.  A p-value < 0.05 was considered to be significant. 
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 Patients'  Gram   Gram   HACEK  Fungi  Culture 
 age   positive   negative   group     negative
 (years)   (%)    (%)   (%)  (%)   (%)
Johnson et al. [2]  0.1–23.1 20 1 – – 79
(1953–1972) (N = 149)
Van Hare et al. [3]  0–20 91 2 5 – 2
(1972–1982) (N = 42)
Fukushige et al. [4]  0.8–17.3 83 – – – 17
(1971–1990) (N = 29)
Awadallah et al. [5]  0.8–32 56 na na 6 11
(1970–1990) (N = 48)
Martin et al. [6]  0.08–18 86 2 5 – 7
(1958–1992) (N = 76)
Saiman et al. [7]  0.09–19 72 11 – 10 7
(1977–1992) (N = 62)
Del Pont et al. [8]  0.08–22 74 – – 13 13
(1978–1994) (N = 43)
Bitar et al. [9]  3–18 66 10 – – 24
(1977–1995) (N = 41)
Stockheim et al. [10] 0.02–20 75 11 5 4 5
(1978–1996) (N = 111)
Sadiq et al. [11]  0.3–16 34 11 – 2 53
(1997–2000) (N = 45)
Geneva Children’s Hospital 0.2–18  44.4 6.7 6.7 20 22.2
(1986–2003) (N = 44)
HACEK group: Hemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella; na: not available, HACEK group and gram negative: 27%
Table 1
Pediatric series on infectious endocarditis.
 Results
44 IE episodes were diagnosed in 43 children (23 girls) 
aged between 1 week and 18 years (median: 7 years). Most 
children originated from northern (n = 20) or sub-Saharan 
(n = 13) Africa, while ten children were from continental 
Europe. 40 patients (91%) with underlying congenital or 
acquired heart disease were referred for cardiac surgery 
(including all children originating from the African con-
tinent).  Among these, 24 (60%) occurred in the postop-
erative period, including 15 cases within the first 2 weeks 
following surgery. Two IE cases occurred in premature 
newborns, and the remaining two in children after liver or 
kidney transplantation. Among those with cardiac disease, 
seven (17.5%) had acquired valvular disease secondary to 
rheumatic fever, 21 (52.5%) had cyanotic and 12 (30%) 
acyanotic congenital heart disease. 
Blood (19 cases with ≥ 2 positive blood cultures, and 
five cases with one positive blood cultures) or perioperative 
specimen cultures and serological tests were positive in 34 
(77%) of the 44 IE episodes. The most frequently observed 
microorganisms were gram-positive organisms (n = 20 
[44.4% of cases]: Staphylococcus aureus [n = 7], Staphylo-
coccus epidermidis [n = 2], and Staphylococcus lugdunensis, 
Streptococcus mitis [n = 2], Streptococcus pyogenes, Strep-
tococcus pneumoniae, Streptococcus milleri, Streptococcus 
sanguis, Enterococcus faecalis, Corynebacterium diphthe-
riae, Propionibacterium acnes, Actinomycetes odontolyti-
cus) and fungi (n = 9 [20%]: Candida albicans [n = 6], Can-
dida guillermondi [n = 2], and Hansenula anomala). Less 
common were microorganisms from the HACEK group 
(n = 3 [6.7%]: Haemophilus paraprophilus, Haemophilus 
influenzae, Haemophilus aphrophilus) and gram-negative 
(n = 3 [6.7%]: Pseudomonas aeruginosa, Bartonella quintana, 
Salmonella typhii), while Coxiella burnetti caused IE in one 
case. Ten cases (22.2%) had culture-negative endocarditis. 
Polymicrobial IE was observed in one case that developed 
a brain abscess secondary to systemic septic emboli.  The 
primary site involvement was equally found in right- (n 
= 19) and left-sided cardiac cavities (n = 20). Four cases 
had multiple intracardiac infective locus at diagnosis. Na-
tive valves were primarily involved in 26 cases, including 
two cases with mitral and aortic valve IE. Secondary IE 
spreading occurred in 18 cases (41%), and included eight 
Dacron patches, a mechanical valve and four cases with 
symptomatic septic embolizations to the brain. Among the 
19 patients with a central venous catheter, seven (36.8%) 
had a catheter-borne IE. The catheters were in place be-
tween 2 and 42 days (median: 12 days) with a trend that 
did not reach statistical significance in duration between 
catheter-borne IE (21.5 ± 16.6 days) and those that were 
not infected (13.5 ± 11.5 days). In 21 cases (48%), broad 
antibiotic (BA) therapy had been given during the 8.4 ± 14 
days prior to IE diagnosis. The use of BA, mainly amino-
penicillins, with or without aminoglycosides, and third-gen-
eration cephalosporins was based in most cases on clinical 
symptoms of fever and elevated inflammatory biological 
parameters suggesting bacterial infection. Four patients 
with negative blood culture IE received BA. Incidence of 
IE during the last 18 years (Figure 1) revealed a fluctuating 
number of yearly diagnosed cases (mean 2.4 per year), with 
no significant difference in the occurrence of gram-posi-
tive, gram-negative, and blood culture-negative IE (Figure 
2) during the two study eras.  
Fungal IE was found in nine cases (20%) and most (n 
= 8) occurred within the second era (p < 0.03). The modi-
fication of the bacteriological techniques that occurred in 
1997 did not influence (p = 0.081) the increase in fungal 
IE diagnosis. Out of the eight fungal IE cases diagnosed 
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Figure 2. Bacteriological pattern of infective endocarditis over two 
9-year periods.
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during the second period, five occurred after November 
1997. In addition, reported experience comparing both 
the BACTEC MYCO/F Lytic bottle and the Isolator sys-
tem did not show improvement in fungal detection [20]. 
Characteristics of patients with and without fungal IE are 
compared in Table 2. On univariate analysis, risk factors 
contributing to fungal IE were: prior administration of BA 
(9/9 cases; p < 0.001) and the presence of an infected cen-
tral venous catheter at the time of IE diagnosis (5/9 cases; p 
= 0.01). The four patients without underlying heart disease 
(two with solid organ transplant and the two prematurely 
born infants) were prone to fungal IE (three of totally nine 
cases; p = 0.023). Although a trend was observed, there was 
no significant difference between fungal IE and IE of other 
causes in the duration of both BA therapy (16.1 ± 21 vs 5.6 
± 9.8 days; p = NS), or of central venous catheter (20 ± 14.4 
vs 13.8 ± 13 days; p = NS). 
The median follow-up after diagnosis of IE was 7 
years (range: 0.4–19 years). Survival was lowest with fun-
gal (56%) and gram-negative (67%) endocarditis. The out-
come of children with gram-positive, HACEK or Q fever, 
and blood culture-negative IE was significantly better, with 
survival rates of 88%, 100% and 80%, respectively. The 
mortality rate did not differ between the two study eras 
(25% vs 16.7%). 
Discussion
The spectrum of organisms identified in pediatric IE has 
been rather uniform during many decades (Table 1). Gram-
positive bacteria were the main cause of IE, whereas fungal 
infections were infrequently described (2–13%). In our in-
stitution, the bacteriological spectrum has evolved during 
the 18-year study period towards more fungal infections, 
albeit the overall incidence of IE did not change. Gram-
positive microorganisms remain the principal cause of IE. 
Still, there was a surprisingly high number of culture-nega-
tive IE throughout the study period. However, although 
Martin et al. [6] showed that 80% of culture-negative IE 
had previous BA treatment, our data did not demonstrate 
this association. Only four (40%) of our patients with nega-
tive culture IE had prior BA. On the other hand, BA was 
given in 17 (50%) of the children with bacteriologically 
identified IE. Although all operated children did receive 
intravenous cephazolin prophylaxis, culture-negative IE 
prevalence was similar in immunocompromised and pre-
mature children. Whether the increase in fungal IE diag-
nosis is solely related to a shift from negative blood culture 
and gram-negative infections is not elicited by our data.
The observed increase of fungal IE in the second era 
goes along with the reported increase of fungal sepsis in 
both adults and children [12, 13, 21, 22]. Although the in-
cidence of invasive fungemia seems to have stabilized in 
recent years, a striking increase ranging from 180- to 620- 
fold was observed between the early 1980s and the 1990s 
in the pediatric and neonatal population [23, 24]. Similar 
to our data, two other pediatric series described a worry-
ing prevalence (10–13%) of fungal IE, but little data about 
these children were available [7, 8].  
Unrelated to the operative status, the use of BA was 
found to be an important risk factor for fungal IE. The 
use of BA was based in most cases on clinical symptoms 
of fever and elevated inflammatory biological parameters 
(such as C-reactive protein), suggesting bacterial infection. 
However, patients who underwent cardiopulmonary by-
pass commonly have elevated C-reactive protein and fever 
in the early postoperative course, impeding the decision to 
introduce BA. Recently, serum procalcitonin has shown 
promising results in identifying bacterial infection after 
cardiac surgery, and may help in a more rational use of 
antibiotics after cardiac surgery, as well as in the immune-
deficient, severely ill child [25, 26]. A second identified risk 
factor for fungal IE was the presence of an infected central 
venous catheter. In a third of the cases, infection of the 
central venous catheter could be identified before infective 
endocarditis was diagnosed. Other predisposing factors for 
fungemia such as neutropenia, mechanical ventilation, par-
enteral nutrition, steroids as well as chemotherapy were ex-
tensively reported [27]. In addition, pediatric experiences 
reported a prolonged length of stay of more than 7 days 
 Fungal IE IE of other  P-value
  causes
 (n = 9)  (n = 34)
Age (years ± SD) 6.65 ± 6.35 8.35 ± 4.89 NS
Female gender (number [%]) 5 (55.5) 18 (53) NS
European origin (number [%]) 3 (33) 7 (20.5) NS
Cyanotic CHD (number [%]) 6 (66.7) 16 (47) NS
Noncardiac diseasea 
(number [%]) 3 (33.3) 1 (2.8) 0.023
Postoperative IE (number [%]) 4 (44.4) 17 (50) NS
Infected CVC (number [%]) 5 (55.5) 2 (5.9) 0.01
Duration of catheter prior to 
IE diagnosis (days ± SD) 20 ± 14.4 13.8 ± 13 NS
BA before IE diagnosis 
(number [%]) 9 (100) 12 (35.3) < 0.001
Duration of BA treatment 
before IE diagnosis (days ± SD) 16.1 ± 21 5.6 ± 9.8 NS
Infected implantable 
materials/total (number) 4/6 6/11 NS
Follow-up (years ± SD) 2.38 ± 1.25 4.47 ± 3.78 NS
Overall survival (%) 55.6 85.7 NS
SD: standard deviation; NS: nonsignificant ; IE: infective endo-
carditis; BA: broad-spectrum antibiotics; CHD: congenital heart 
disease; CVC: central venous catheter; a noncardiac disease: post-
transplantation and prematurity
Table 2
Difference between fungal and infective endocarditis of other 
causes.
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in the ICU, and low birthweight as predisposing factors 
to fungemia [28, 29]. Our data clearly demonstrated the 
relation between some predisposing factors and the de-
velopment of fungal IE, suggesting that early indices of 
suspicion for fungal IE should be considered especially if 
predisposing factors are met. Although no definite recom-
mendations exist for fungal screening in pediatric non-im-
munocompromised critically ill children, calculation of a 
fungal colonization index based on multi-site screening 
may help to diagnose invasive fungemia if predisposing 
factors are met [30].
 The mortality rate in previously published series on 
pediatric IE ranges between 3% and 25% [2–11]. We 
encountered an overall mortality reaching 21%, with no 
difference between the two study eras. In our cohort, the 
elevated mortality may be influenced by the increased 
number of children with cardiac disease and the associated 
mortality. 
Besides the retrospective design of this study, the lack 
of information on the volume of blood drawn is an impor-
tant shortcoming of this study as it is known that a suffi-
cient volume is critical for bacterial isolation [31]. 
In conclusion, although limited by a relatively small 
series and a referral bias related to the large cohort of car-
diac patients, our data suggest a rise in the prevalence of 
fungal IE, which is associated with the use of BA and cen-
tral venous catheters. Fungal IE has a high risk of mortality 
(44%); early diagnosis and treatment might be crucial for 
the outcome of affected children. 
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